C.R. Bard Inc. had a tough road ahead earlier this year to convince a jury that its pelvic mesh device, used to treat urinary incontinence, didn’t cause a woman’s severe pain.
The jury was in the traditionally more plaintiff-friendly venue of Missouri state court. The trial lasted more than two months — longer than any other pelvic mesh trial.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
